The life sciences contain the branches of science that include the scientific study of living organisms for instance microorganisms, plants, animals, and human beings along with related thoughts like bioethics. Life science instrumentationcontains all the equipment’s utilized in the detection, prediction and analysis of living organism and their operative. It has wide range in biotechnology companies, Pharmaceutical companies and at times in health care industry as well. It is a result of technological improvement in the field of science, thus causing automation in the procedure of analyzing and detection of different components of living cells. The utilization of improvements technologies and combining the technologies with computer systems, as a result a more correct and precise results are obtained.
How Big is the Global Life Science Instrumentation Market?
The Life Science Instrumentation Market is expected to exceed more than US$ 89 Billion by 2027 at a CAGR of 6.8% in the given forecast period.
The major driving factors of Life Science Instrumentation Market are as follows:
The restraining factors of Life Science Instrumentation Market are as follows:
The Life Science Instrumentation Market is segmented on the lines of its product, end user, application and regional. Based on product segmentation it coverscell counting, centrifuges, chromatography, electrophoresis, flow cytometry, immunoassays, liquid handling and robotics, microscopy, next-generation sequencing (NGS), PCR, spectroscopy, western blotting, other instruments. Based on end user segmentation it covers cell counting, centrifuges, chromatography, electrophoresis, flow cytometry, immunoassays, liquid handling and robotics, microscopy, next-generation sequencing (NGS), PCR, spectroscopy, western blotting, other instruments. Based on application segmentation it covers research applications, clinical and diagnostic applications, other applications (Industrial Chemistry, Food & Beverage Testing, Environment Testing, Forensic Applications, Cosmetic Industry, and Petrochemical Industry). The Life Science Instrumentation Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Life Science Instrumentation Market and related technologies.
2) Analyses of global market trends, with data from 2019, estimates for 2020 and 2021, and projections of compound annual growth rates (CAGRs) through 2027.
3) Identifications of new market opportunities and targeted promotional plans for Life Science Instrumentation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Life Science Instrumentation Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Life Science Instrumentation Market has been segmented as below:
By Technology Analysis:
By End User Analysis:
By Application Analysis:
By Regional Analysis:
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Life Science Instrumentation Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Life Science Instrumentation Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Breakdown of Primaries
2.2.2.2 Key Data From Primary Sources
2.3 Life Science Instrumentation Market Size Estimation
2.3.1.1 Bottom-Up Approach
2.3.1.2 Top-Down Approach
2.4 Research Design
2.5 Life Science Instrumentation Market Breakdown and Data Triangulation
2.6 Research Assumptions
3 Executive Summary
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion
4 Premium Insights
4.1 Global Life Science Instrumentation Market Overview
4.2 Geographic Analysis: Life Science Instrumentation Market, By Technology, 2016
4.3 Life Science Instrumentation Market, By Application (2016 vs 2021)
4.4 Geographical Snapshot of the Life Science Instrumentation Market, 2016
4.5 Life Cycle Analysis, By Region
5 Market Overview
5.1 Introduction
5.2 Life Science Instrumentation Market Segmentation
5.3 Life Science Instrumentation Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Spending on Pharmaceutical R&D Across the Globe
5.3.1.2 Growing Food Safety Concerns
5.3.1.3 Technological Advancements in Analytical Devices
5.3.1.4 Growth in Funding for Research
5.3.2 Restraints
5.3.2.1 High Cost of Instruments
5.3.2.2 Presence of Alternative Technologies
5.3.2.3 Dearth of Skilled Professionals
5.3.3 Opportunities
5.3.3.1 Emerging Markets Offer Lucrative Growth Opportunities
5.3.3.2 Rising Demand of Analytical Instruments With Growing Research Activities in Proteomics
5.3.3.3 Increasing Demand From Various Industries
5.3.4 Challenges
5.3.4.1 Inadequate Infrastructure for Research in Emerging Countries
5.3.4.2 Survival of Small Players
6 Industry Insights
6.1 Introduction
6.2 Value Chain Analysis
6.3 Life Science Instrumentation Market Indicators
6.3.1 Increasing R&D Spending in the Pharmaceutical and Biotech Sectors
6.4 Industry Trends
6.4.1 Rising Focus of Market Players Towards the Development of Miniaturized Instruments
6.4.2 Increasing Adoption of Hyphenated Technologies
6.4.3 Tie-Ups Between Analytical Instrument Manufacturers and Research Laboratories/Academic Institutions
6.5 Porter’s Five Forces Analysis
6.5.1 Threat of New Entrants
6.5.2 Threat From Substitutes
6.5.3 Bargaining Power of Suppliers
6.5.4 Bargaining Power of Buyers
6.5.5 Intensity of Competitive Rivalry
7 Life Science Instrumentation Market, By Technology
7.1 Introduction
7.2 Spectroscopy
7.2.1 Drivers
7.2.1.1 Atomic Spectroscopy to Aid in Drug Safety Process
7.2.2 Restraints
7.2.2.1 High Costs
7.2.3 Spectroscopy Market, By Type
7.2.3.1 Molecular Spectroscopy
7.2.3.1.1 Market Share Analysis, By Key Player
7.2.3.2 Mass Spectrometry
7.2.3.2.1 Market Share Analysis, By Key Player
7.2.3.3 Atomic Spectroscopy
7.2.3.3.1 Market Share Analysis, By Key Player
7.3 Chromatography
7.3.1 Drivers
7.3.1.1 New International Gmp & Gdp Certification for Pharmaceutical Excipients (North America & Europe): Excipact
7.3.1.2 Industry Support to Research Laboratories and Academic Institutes
7.3.1.3 Rise in Government Investments for Chromatography Technologies
7.3.1.4 Growing Importance of Chromatography Tests in Drug Approvals
7.3.2 Restraints
7.3.2.1 High Cost of Equipment
7.3.3 Chromatography Market, By Type
7.3.3.1 Liquid Chromatography (LC) Systems
7.3.3.2 Gas Chromatography (GC) Systems
7.3.3.3 Supercritical Fluid Chromatography (SFC) Systems
7.3.3.4 Thin-Layer Chromatography (TLC) Systems
7.3.4 Market Share Analysis, By Key Player
7.4 Microscopy
7.4.1 Drivers
7.4.1.1 Rising Focus on Nanotechnology
7.4.1.2 Public-Private Investments for the Development of Advanced Microscopes
7.4.1.3 Technological Advancements
7.4.2 Restraints
7.4.2.1 High Cost of Advanced Microscopes
7.4.3 Microscopy Market, By Type
7.4.3.1 Optical Microscopy
7.4.3.1.1 Market Share Analysis, By Key Player
7.4.3.2 Electron Microscopy
7.4.3.2.1 Market Share Analysis, By Key Player
7.4.3.3 Scanning Probe Microscopy
7.4.3.3.1 Market Share Analysis, By Key Player
7.4.3.4 Confocal Microscopy
7.4.3.4.1 Market Share Analysis, By Key Player
7.5 PCR
7.5.1 Drivers
7.5.1.1 Rising Incidences of Infectious Diseases and Genetic Disorders
7.5.1.2 Technological Advancements
7.5.2 Restraints
7.5.2.1 High Device Costs Associated With DPCR
7.5.2.2 Technical Limitations of QPCR and DPCR
7.5.3 PCR Market, By Type
7.5.3.1 QPCR
7.5.3.1.1 QPCR Market Share Analysis (2015)
7.5.3.2 Digital PCR (DPCR)
7.5.3.2.1 DPCR Market Share Analysis (2015)
7.6 Flow Cytometry
7.6.1 Drivers
7.6.1.1 Technological Advancements in Flow Cytometry Instruments
7.6.1.2 Growing Adoption of Flow Cytometry Techniques in Research Activities
7.6.2 Restraints
7.6.2.1 High Cost of Instruments
7.6.2.2 Lack of Awareness and Dearth of Training
7.6.3 Flow Cytometry Market, By Type
7.6.3.1 Cell-Based Flow Cytometry
7.6.3.2 Bead-Based Flow Cytometry
7.6.4 Market Share Analysis, By Key Player
7.7 Immunoassays
7.7.1 Drivers
7.7.1.1 Rising Incidence of Chronic and Infectious Diseases in Emerging Economies
7.7.1.2 Sensitivity, Low Cost, and Rapid Analysis Offered By Immunoassays
7.7.1.3 Increasing Health Awareness
7.7.2 Restraints
7.7.2.1 Low Detection Restricts Adoption of Immunoassay Tests
7.7.3 Market Share Analysis, By Key Player
7.8 Liquid Handling and Robotics
7.8.1 Drivers
7.8.1.1 Rising Labor Costs Driving the Need for Automation
7.8.1.2 Technological Advancements to Boost the Adoption of Liquid Handling and Robotics Systems
7.8.2 Restraints
7.8.2.1 Reluctance of Small and Medium-Sized Labs Towards the Adoption of Automation
7.8.3 Liquid Handling Market, By Type
7.8.3.1 Automatic Liquid Handling
7.8.3.2 Manual Liquid Handling
7.8.4 Standalone Robots Market, By Type
7.8.4.1 Robotic Arms
7.8.4.2 Track Robot Systems
7.9 Centrifuges
7.9.1 Drivers
7.9.1.1 Technological Advancements
7.9.1.2 Increasing Biopharmaceutical Research Activities
7.9.2 Restraints
7.9.2.1 Long Equipment Lifespan Leads to Low Sales of Centrifuges
7.9.3 Centrifuges Market, By Type
7.9.3.1 Microcentrifuges
7.9.3.2 Multipurpose Centrifuges
7.9.3.3 Floor-Standing Centrifuges
7.9.3.4 Ultracentrifuges
7.9.4 Market Share Analysis, By Key Player
7.10 Electrophoresis
7.10.1 Drivers
7.10.1.1 Increasing Government Funding for Research on Electrophoresis Technique
7.10.1.2 Growing Number of Industry-Academic Research Collaborations
7.10.1.3 Growing Use of Capillary Electrophoresis (CE) With Mass Spectroscopy (MS)
7.10.2 Restraints
7.10.2.1 Presence of Alternative Technologies Offering Better Efficiency & Results
7.10.2.2 Time-Consuming Operations and Limited Sample Analysis
7.10.3 Electrophoresis Market, By Type
7.10.3.1 Gel Electrophoresis Systems
7.10.3.2 Capillary Electrophoresis Systems
7.10.4 Market Share Analysis, By Key Player
7.11 Cell Counting
7.11.1 Drivers
7.11.1.1 Growing Application in Diagnosis of Cancer and Aids
7.11.1.2 Corporate & Government Funding and Investments for Cell-Based Research
7.11.1.3 Development of Enhanced Informatics Solutions and Improved Image Analysis Instruments
7.11.2 Restraints
7.11.2.1 High Prices of Advanced Cell Counting Systems
7.11.2.2 Reluctance Among Researchers to Use Advanced Cell Counting Techniques
7.11.3 Cell Counting Market, By Type
7.11.3.1 Automated Cell Counters
7.11.3.2 Hemocytometers and Manual Cell Counters
7.11.4 Market Share Analysis, By Key Player
7.12 Next-Generation Sequencing (NGS)
7.12.1 Drivers
7.12.1.1 Focus on Technological Advancements in Sequencing Platforms
7.12.1.2 Increasing Applications of NGS
7.12.1.3 Conferences and Workshops Increasing Awareness on NGS Products and Services
7.12.1.4 Growing Partnerships and Collaborations
7.12.2 Restraints
7.12.2.1 Accuracy & Standardization Concerns in Diagnostic Testing
7.12.3 Market Share Analysis, By Key Player
7.13 Western Blotting
7.13.1 Drivers
7.13.1.1 Technological Advancements and Instrument Automation
7.13.1.2 Use of Western Blotting for Antibody Validation
7.13.2 Restraints
7.13.2.1 High Cost of Primary Antibodies
7.13.2.2 Emergence of Alternative Technologies
7.13.3 Western Blotting Market, By Type
7.13.3.1 Semi-Automated Instruments
7.13.3.2 Automated Instruments
7.13.3.3 Manual Instruments
7.13.4 Market Share Analysis, By Key Player
7.14 Other Technologies
7.14.1 Laboratory Freezers
7.14.1.1 Freezers
7.14.1.2 Refrigerators
7.14.1.3 Cryopreservation Systems
7.14.2 Heat Sterilization
7.14.2.1 Moist Heat Sterilization (Autoclaves)
7.14.2.2 Dry Heat
7.14.3 Microplate Systems
7.14.3.1 Microplate Readers
7.14.3.2 Microplate Dispensers
7.14.3.3 Microplate Washers
7.14.4 Laboratory Balances
7.14.5 Colorimeters
7.14.6 Incubators
7.14.7 Fume Hoods
8 Life Science Instrumentation Market, By Application
8.1 Introduction
8.2 Research Applications
8.3 Clinical and Diagnostic Applications
8.4 Other Applications
9 Life Science Instrumentation Market, By End User
9.1 Introduction
9.2 Cell Counting
9.2.1 Research Institutions
9.2.2 Hospitals and Diagnostic Laboratories
9.2.3 Pharmaceutical and Biotechnology Companies
9.2.4 Other End Users
9.3 Centrifuges
9.3.1 Hospitals
9.3.2 Biotechnology and Pharmaceutical Companies
9.3.3 Academic and Research Institutes
9.4 Chromatography
9.4.1 Pharmaceutical Companies and CROs
9.4.2 Biotechnology and Biopharmaceutical Companies
9.4.3 Academic Research Laboratories
9.4.4 Agriculture & Food Industry
9.4.5 Environmental Testing
9.4.6 Other End Users
9.5 Electrophoresis
9.5.1 Academic Institutions
9.5.2 Pharmaceutical and Biotechnology Companies
9.5.3 Research Organizations
9.5.4 Hospitals and Diagnostic Centers
9.6 Flow Cytometry
9.6.1 Pharmaceutical and Biotechnology Companies
9.6.2 Medical Schools and Academic Institutions
9.6.3 Hospitals
9.6.4 Research Institutes
9.6.5 Clinical Testing Labs
9.7 Immunoassay
9.7.1 Hospitals
9.7.2 Clinical Laboratories
9.7.3 Pharmaceutical Companies, CROs, and Biotechnology Companies
9.7.4 Blood Banks
9.7.5 Academic Research Centers
9.7.6 Other End Users
9.8 Liquid Handling and Robotics
9.8.1 Biotechnology and Pharmaceutical Companies
9.8.2 Research Institutes
9.8.3 Hospitals and Private Labs
9.8.4 Academic Institutes
9.9 Microscopy
9.9.1 Academic Institutes
9.9.2 Industries
9.9.3 Other End Users
9.10 Next-Generation Sequencing
9.10.1 Research Centers and Academic & Government Institutes
9.10.2 Hospitals and Clinics
9.10.3 Pharmaceutical and Biotechnology Companies
9.10.4 Other End Users
9.11 PCR
9.11.1 Hospitals and Diagnostic Centers
9.11.2 Research Laboratories and Academic Institutes
9.11.3 Pharmaceutical and Biotechnology Companies
9.11.4 Clinical Research Organizations
9.11.5 Forensic Laboratories
9.12 Spectroscopy
9.12.1 Pharmaceutical Companies, CROs, and Biotechnology Companies
9.12.2 Food and Beverage Industry
9.12.3 Environmental Testing
9.12.4 Industrial Chemistry
9.12.5 Academic Institutions
9.12.6 Other End Users
9.13 Western Blotting
9.13.1 Research Institutes
9.13.2 Pharmaceutical and Biotechnology Companies
9.13.3 Diagnostic Laboratories
9.14 Other Technologies
9.14.1 Pharmaceutical Companies, CROs, and Biotechnology Companies
9.14.2 Research Laboratories
9.14.3 Academic Institutions
9.14.4 Others End Users
10 Life Science Instrumentation Market, By Region
10.1 Introduction
10.2 North America
10.2.1 Funding in Medical Research May Develop New Application Areas for Analytical Technologies
10.2.2 Stringent Regulations Driving the Use of Analytical Instruments in Drug Development
10.2.3 Growing Metabolomics Research in the U.S.
10.2.4 Conferences, Discussions, Symposiums, & Seminars
10.3 Europe
10.3.1 Public-Private Investments in R&D Activities
10.3.2 Rising Awareness on Advanced Analytical Instruments
10.3.3 Developing Pharmaceutical Sector in Russia
10.4 Asia-Pacific
10.4.1 Strategic Expansions By Key Market Players in Emerging Asian Countries
10.4.2 Rising Crop Research Studies in Asia
10.4.3 Government Investments in Chinese Biomedical Industry Driving the Demand for Analytical Instruments
10.4.4 Singapore, an Important Market for Life Science Instrumentation
10.4.5 Increasing Conferences, Exhibitions, & Meetings on Analytical Instruments
10.5 Rest of the World
10.5.1 Flourishing Biotechnology & Pharmaceutical Markets in Brazil and Mexico
10.5.2 Increasing R&D Funding in the Latin American Region
10.5.3 High Prevalence of Hiv in African Region
11 Competitive Landscape
11.1 Introduction
11.2 Strategic Overview
11.3 Competitive Situation and Trends
11.3.1 Product Launches, Enhancements, and Showcase
11.3.2 Agreements, Partnerships, and Collaborations
11.3.3 Expansion
11.3.4 Mergers & Acquisitions
11.3.5 Other Developments
12 Company Profiles
12.1 Introduction
12.2 Waters Corporation
12.3 Becton, Dickinson and Company
12.4 Perkinelmer, Inc.
12.5 Shimadzu Corporation
12.6 Thermo Fisher Scientific, Inc.
12.7 F. Hoffmann-La Roche Ltd.
12.8 Bio-Rad Laboratories, Inc.
12.9 Bruker Corporation
12.10 Agilent Technologies, Inc.
12.11 Danaher Corporation
The Life Science Instrumentation Market has been segmented as below:
By Technology Analysis:
By End User Analysis:
By Application Analysis:
By Regional Analysis:
